Operating Segments - Schedule of operating segments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Revenues	$ 824,268	$ 2,359,447
Loss from Operations	(13,140,885)	(18,586,507)
Amortization and Depreciation Expense	34,161	62,372
Other (Expense)/Income, Net	(274,830)	61,092
Share-Based Compensation	361,559	409,933
Identifiable Assets	26,869,927	19,891,235
Public Health Solutions [Member]
Segment Reporting Information [Line Items]
Revenues	824,268	2,242,078
Loss from Operations	(647,600)	(85,417)
Amortization and Depreciation Expense	16,801	21,672
Share-Based Compensation	21,884	47,453
Identifiable Assets	146,296	147,784
Specialized BioTherapeutics [Member]
Segment Reporting Information [Line Items]
Revenues		117,369
Loss from Operations	(7,280,936)	(13,610,715)
Amortization and Depreciation Expense	7,804	11,839
Other (Expense)/Income, Net	135,409	71,974
Share-Based Compensation	136,594	148,107
Identifiable Assets	128,645	176,447
Corporate [Member]
Segment Reporting Information [Line Items]
Loss from Operations	(5,212,349)	(4,890,375)
Amortization and Depreciation Expense	9,556	28,861
Other (Expense)/Income, Net	(410,239)	(10,882)
Share-Based Compensation	203,081	214,373
Identifiable Assets	$ 26,594,986	$ 19,567,004